Next Article in Journal
Mandatory Biological/Targeted Synthetic Disease-Modifying Antirheumatic Drugs Dose Reduction on Risk of Serious Infections in Patients with Rheumatoid Arthritis: A Nationwide Nested Case–Control Study
Previous Article in Journal
Dasatinib Inhibits Basal B Breast Cancer Through ETS1-Mediated Extracellular Matrix Remodeling
Previous Article in Special Issue
Pleiotropic Effects of Oral Anticoagulant Therapy: Is There a Difference Between VKAs and DOACs?
 
 
Review

Article Versions Notes

Biomedicines 2025, 13(12), 2889; https://doi.org/10.3390/biomedicines13122889
Action Date Notes Link
article pdf uploaded. 26 November 2025 15:17 CET Version of Record https://www.mdpi.com/2227-9059/13/12/2889/pdf-vor
article pdf uploaded. 26 November 2025 15:38 CET Updated version of record https://www.mdpi.com/2227-9059/13/12/2889/pdf-vor
article xml file uploaded 27 November 2025 06:55 CET Original file -
article xml uploaded. 27 November 2025 06:55 CET Update -
article pdf uploaded. 27 November 2025 06:55 CET Updated version of record https://www.mdpi.com/2227-9059/13/12/2889/pdf-vor
article html file updated 27 November 2025 06:59 CET Original file -
article xml file uploaded 27 November 2025 10:59 CET Update -
article xml uploaded. 27 November 2025 10:59 CET Update https://www.mdpi.com/2227-9059/13/12/2889/xml
article pdf uploaded. 27 November 2025 10:59 CET Updated version of record https://www.mdpi.com/2227-9059/13/12/2889/pdf
article html file updated 27 November 2025 11:00 CET Update https://www.mdpi.com/2227-9059/13/12/2889/html
Back to TopTop